CHAPTER 14 Depression and suicide in older people
FRAMEWORK
This chapter examines the issues of depression and suicide in older people. The definition of what constitutes depression in older people is discussed and the difficulty in gathering prevalence data is identified. Obtaining a clear diagnosis is often difficult and can become clouded by issues of loss and grief. The importance of distinguishing depression from confusion, medication effects and delirium is raised and the ongoing issue of demoralisation through adversity is of concern. Risk assessment undertaken by a well-trained health care worker should be done routinely when an older person presents with health problems. The use of antidepressant medication must be monitored well and initial doses are usually lower with increasing amounts given according to reactions. The authors discuss suicide in older people, the spectrum of suicidal behaviours, and the risk factors, with management issues described. Early recognition and treatment of depression is seen as the important preventative intervention for suicide. [RN, SG]
Introduction
Depression and suicide are two closely linked and pertinent issues for older people. Depression is the leading mental illness to affect older people and it is the major risk factor for suicide. In Australia and other developed countries, older men have one of the highest rates for suicide. This chapter examines recent developments in the management of depression and suicide in older people and discusses some of the more controversial aspects of this topic.
Depression
Epidemiology
Although there are quite a number of different types of depression recognised in nosologies such as the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV-TR) of the American Psychiatric Association (2000), the archetypal depressive illness is the one referred to as ‘major depression’. It is this type of clinically significant depression that will be emphasised in this chapter. However, it is worth noting that chronic low-grade depression is referred to as dysthymia and depressive reactions to adverse life events that do not meet diagnostic criteria for major depression are referred to as ‘adjustment disorders with depressed mood’. However, major depression remains major depression regardless of whether it has occurred in the context of an adverse life event.
The prevalence of major depression in older people is the subject of some dispute (O’Connor 2006). In particular, there is a debate about whether its prevalence actually declines with age as indicated by large-scale epidemiological studies. Many of these studies systematically excluded people who were not living at home at the time of the survey. So older people in hostels, nursing homes and hospitals were generally not counted. We know that the prevalence of depression in these settings is much higher than in the general community, so it is likely that population studies that are based on doorknock surveys have systematically underestimated the number of older people with depression. In addition, the survey instruments commonly used to generate diagnoses of depression, such as the Diagnostic Interview Schedule (DIS) or the Composite International Diagnostic Interview (CIDI), usually exclude symptoms that might be due to general medical conditions. This is not such a problem in young and middle-aged populations, but in older people may have the effect of under-counting symptoms of depression, as older people have a much higher prevalence of general medical problems.
The Australian National Survey of Mental Health and Wellbeing of Adults (McLennan 1998) found that less than 1% of men and less than 2% of women aged 65 years and over living in the community met diagnostic criteria for a depressive disorder. However, this survey did not include older people in residential aged care settings and it is now well established that between 6% and 18% of older people living in aged hostels and nursing homes are suffering from a depressive disorder. The prevalence of depression in older people receiving domiciliary nursing care and in older hospital inpatients is reported to be even higher. In a US study (Steffens et al 2000) that surveyed community and institutionalised older people in Cache County, Utah, the point prevalence of major depression was 2.7% in men and 4.4% in women and the estimated lifetime prevalence of depression was 9.6% in men and 20.4% in women.
Differential diagnosis
In older people it is particularly important to distinguish depression from grief and demoralisation (Clarke & Kissane 2002). Grief is a normal human response to loss and is a very common experience among older people (Byrne & Raphael 1997). Symptoms of grief include crying, thoughts about the deceased, insomnia, a sense of presence of the deceased, hallucinations of the deceased and thoughts of death. Although the manifestations of grief vary considerably between cultures, grief tends to come in waves, the so-called ‘pangs’ of grief, and generally settles spontaneously with the passage of time and without treatment. Grief may be pathologically severe or prolonged in cases where the death was traumatic or unexpected or in cases where the attachment was ambivalent. Grief counselling may be warranted in such cases. In Western culture, at least, grief is associated with considerable tearfulness whereas depression is often associated with an inability to cry. One implication of this is that it is important to allow people to grieve in their own culturally appropriate way and to avoid medicalising a common, normal phenomenon. However, in a minority of cases grief is complicated by depression and this depression requires treatment in the usual manner. Depression complicating grief may be associated with pervasive anhedonia or the development of suicidal intent.
Demoralisation is a common consequence of adversity, particularly where this is prolonged. Many older people with chronic medical conditions or chronic disability following acute medical conditions such as heart attack or stroke develop demoralisation. This is not the same as depression. Treatment of demoralisation requires a different approach (see Clarke & Kissane 2002).
Parkinson’s disease is often associated with a paucity of movement (bradykinesia) and with a reduction in facial expression. These clinical features can easily be mistaken for depression. However, Parkinson’s disease is also commonly associated with depression.
Psychological treatments
The main evidence-based psychological treatments used in depression are cognitive behaviour therapy (CBT) and interpersonal psychotherapy (IPT). Although most clinical trials of CBT and IPT have been conducted in young and middle-aged people, there is a growing body of evidence that suggests that these treatments are also effective in older people (Laidlaw et al 2003). In the oldest of the old it is necessary to modify the application of the standard techniques used in these treatments. For instance, it is often necessary to increase the number of sessions and decrease the homework requirements. Sensory impairment (vision and hearing) and cognitive impairment are both significant challenges to psychological treatment. Although CBT and IPT have traditionally been administered by clinical psychologists or psychiatrists, they can be administered by trained therapists from any disciplinary background.
A recent systematic review has suggested that behaviour therapy (BT) might be as effective as CBT in the treatment of depression (Ekers et al 2008). If this is confirmed, it is likely to be very important for the management of depression in older people. Pleasant events scheduling, physical activity, exposure techniques, and other BT interventions are often easier to implement in older people than formal CBT.
Drug treatments
The number needed to treat (NNT) for most modern antidepressants lies between three and five. In other words, one patient with depression will respond to pharmacological treatment for every three to five patients treated. That does not mean that only one in three to five patients will get better, but it does mean that only one in three to five gets better due to the antidepressant. The usual response rate in antidepressant trials is about 60%, of which about 35% is due to the placebo effect and about 25% is due to the effect of the drug.